Mark E. Boulding
2020
In 2020, Mark E. Boulding earned a total compensation of $3.5M as Executive Vice President and Chief Legal Officer at PTC Therapeutics, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $298,700 |
|---|---|
| Option Awards | $2,214,150 |
| Salary | $488,854 |
| Stock Awards | $521,832 |
| Other | $16,800 |
| Total | $3,540,336 |
Boulding received $2.2M in option awards, accounting for 63% of the total pay in 2020.
Boulding also received $298.7K in non-equity incentive plan, $488.9K in salary, $521.8K in stock awards and $16.8K in other compensation.
Rankings
In 2020, Mark E. Boulding's compensation ranked 3,273rd out of 13,090 executives tracked by ExecPay. In other words, Boulding earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,273 out of 13,090 | 75th |
Division Manufacturing | 1,271 out of 5,621 | 77th |
Major group Chemicals And Allied Products | 480 out of 2,254 | 79th |
Industry group Drugs | 416 out of 1,954 | 79th |
Industry Pharmaceutical Preparations | 310 out of 1,459 | 79th |
Source: SEC filing on April 29, 2021.
Boulding's colleagues
We found five more compensation records of executives who worked with Mark E. Boulding at PTC Therapeutics in 2020.
2020
Stuart Peltz
PTC Therapeutics
Chief Executive Officer
2020
Marcio Souza
PTC Therapeutics
Chief Operating Officer
2020
Eric Pauwels
PTC Therapeutics
Chief Business Officer
2020
Neil Almstead
PTC Therapeutics
Chief Technical Operations Officer
2020
Emily Hill
PTC Therapeutics